For-Profit Approach in Psychedelic Medicine| Florian Brand , CEO, ATAI Life Sciences NV. 00:10:00
This exploration delves into the ethical and practical considerations surrounding the integration of for-profit models within the emerging field of psychedelic medicine, examining its implications for accessibility, patient care, and societal values.